Publication

The Association of Lipids and Lipoproteins with Hip Fracture Risk: The Cardiovascular Health Study

Downloadable Content

Persistent URL
Last modified
  • 09/17/2025
Type of Material
Authors
    Joshua Barzilay, Emory UniversityPetra Buzkova, University of WashingtonLewis H Kuller, University of PittsburghJane A Cauley, University of PittsburghHoward A Fink, VA Health Care System, MinneapolisKerry Sheets, University of Minnesota, MinneapolisJohn A Robbins, University of California DavisLaura D Carbone, Augusta UniversityRachel E Elam, Augusta UniversityKenneth J Mukamal, Beth Israel Deaconess Medical Center
Language
  • English
Date
  • 2022-08-26
Publisher
  • ELSEVIER SCIENCE INC
Publication Version
Copyright Statement
  • © 2022 Elsevier Inc. All rights reserved.
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 135
Issue
  • 9
Start Page
  • 1101
End Page
  • +
Grant/Funding Information
  • Additional support was provided by R01AG023629 from the National Institute on Aging (NIA). A full list of principal CHS investigators and institutions can be found at CHS-NHLBI.org.
  • This research was supported by contracts HHSN268201200036C, HHSN268200800007C, HHSN268201800001C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, 75N92021D00006, and grants U01HL080295 and U01HL130114 from the National Heart, Lung, and Blood Institute (NHLBI), with additional contribution from the National Institute of Neurological Disorders and Stroke (NINDS).
Supplemental Material (URL)
Abstract
  • Background: It is uncertain if lipids or lipoproteins are associated with osteoporotic fractures. In this study, incident hip fracture risk according to conventional lipid levels and lipoprotein levels and sizes was examined. Methods: We followed 5832 participants aged ≥65 years from the Cardiovascular Health Study for hip fracture for a mean of 13.5 (SD 5.7) years. Standard enzymatic methods were used to determine lipid levels (ie, high-density lipoprotein-cholesterol [HDL-c], low-density lipoprotein-cholesterol [LDL-c], and triglycerides). Nuclear magnetic resonance spectroscopy was used to measure lipoprotein fractions (ie, very-low-density lipoprotein-particle [VLDL-P], low-density lipoprotein-particle [LDL-P], high-density lipoprotein-particle [HDL-P]) in a subset of 1849 participants. Results: We documented 755 incident hip fractures among women (1.19 fractures per 100 participant years [95% confidence interval, 1.04, 1.35]) and 197 among men (0.67 fractures per 100 participant years [95% CI, 0.41, 1.10]) over an average follow-up. HDL-c and LDL-c levels had statistically significant nonlinear U-shaped relationships with hip fracture risk (HDL-c, P =.009; LDL-c, P =.02). Triglyceride levels were not significantly associated with hip fracture risk. In fully adjusted conjoint models, higher VLDL-P concentration (hazard ratio [HR] per 1 standard deviation [SD] increment 1.47 [1.13, 1.91] and size [HR per 1 SD increment 1.24 [1.05, 1.46]) and higher high-density lipoprotein particle size (HR per 1 SD increment 1.81 [1.25, 2.62]) were all associated with higher hip fracture risk. Conclusions: Lipids and lipoproteins are associated with hip fracture risk in older adults. The associations are complex. Mechanistic studies are needed to understand these findings.
Author Notes
  • Joshua Barzilay MD, 3650 Steve Reynolds Blvd, Duluth GA, 30096; Tel 404 365 4207; Fax 770 931 6365. Email: joshua.barzilay@kp.org
Keywords

Tools

Relations

In Collection:

Items